Substituted long chain alcohol xanthine compounds
AssigneeCell Therapeutics, Inc.
InventorsGail Underiner, David Porubek, J. Peter Klein, Paul Woodson
Life of this patent
Estimating the term…
Loading patent…
AssigneeCell Therapeutics, Inc.
InventorsGail Underiner, David Porubek, J. Peter Klein, Paul Woodson
Estimating the term…
There is disclosed compounds and pharmaceutical compositions comprising compounds of the formula: ##STR1## wherein each of one or two R is independently ##STR2## wherein n is an integer from 7 to 20, at least one of X or Y is --OH and if one of X or Y is --OH then the other X or Y is H, CH.sub.3, CH.sub.3 --CH.sub.2, CH.sub.3 --(CH.sub.2).sub.2 --, or (CH.sub.3).sub.2 --CH.sub.2 --, and W.sub.1, W.sub.2, and W.sub.3 is independently H, CH.sub.3, CH.sub.3 --CH.sub.2, CH.sub.3 --(CH.sub.2).sub.2 --, or (CH.sub.3).sub.2 --CH.sub.2 --, and wherein the alkyl groups may be substituted by a hydroxyl, halo or dimethylamino group and/or interrupted by an oxygen atom, H or alkyl (1-4C), including resolved enantiomers and/or diastereomers, salts and mixtures thereof. In particular, the compounds lower elevated levels of unsaturated, non-arachidonate phosphatidic acid (PA) and diacylglycerol (DAG) derived from said PA within seconds of the primary stimulus and their contact with said cells. The modulatory effect depends on the nature of the target cell and the stimulus applied.
A compound of the formula:
A pharmaceutical composition comprising a compound selected from the group consisting of N-(8-hydroxynonyl)theobromine, N-(9-hydroxydecanyl)theobromine, N-(10-hydroxydecanyl)theobromine, N-(8,9-dihydroxynonyl)theobromine, N-(9,10-dihydroxydecyl)theobromine and combinations thereof, and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.